Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001513460 | SCV001721078 | benign | Developmental and epileptic encephalopathy, 36 | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001513460 | SCV002795249 | likely benign | Developmental and epileptic encephalopathy, 36 | 2022-03-25 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001702103 | SCV005277916 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome Diagnostics Laboratory, |
RCV001702103 | SCV001930554 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001702103 | SCV001964566 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003921099 | SCV004731414 | likely benign | ALG13-related disorder | 2019-05-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |